Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Prepaid Assets (2020 - 2025)

Cytek Biosciences' Prepaid Assets history spans 6 years, with the latest figure at $3.0 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 53.22% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, up 53.22%, while the annual FY2025 figure was $3.0 million, 53.22% up from the prior year.
  • Prepaid Assets reached $3.0 million in Q4 2025 per CTKB's latest filing, down from $18.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $18.5 million in Q3 2025 to a low of $95000.0 in Q3 2021.
  • Average Prepaid Assets over 5 years is $5.2 million, with a median of $2.5 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: skyrocketed 13932.63% in 2022, then tumbled 90.42% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $1.9 million in 2021, then skyrocketed by 591.62% to $13.0 million in 2022, then tumbled by 82.79% to $2.2 million in 2023, then fell by 12.87% to $1.9 million in 2024, then soared by 53.22% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Prepaid Assets are $3.0 million (Q4 2025), $18.5 million (Q3 2025), and $2.8 million (Q2 2025).